Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,795 USD | -0,18% | +10,91% | -12,11% |
07/03 | Lumos Pharma, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
07/03 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
Vakgebied
Aantal werknemers: 33
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Hawkins
CEO | Chief Executive Officer | 75 | 01-09-10 |
Lori Lawley
DFI | Director of Finance/CFO | 40 | 01-03-20 |
John McKew
PSD | President | 59 | 01-01-16 |
Chief Tech/Sci/R&D Officer | - | 01-05-22 | |
Bradley Powers
CMP | Compliance Officer | 45 | 03-08-19 |
Robert J. Davis
COO | Chief Operating Officer | - | 01-05-20 |
Lisa Miller
IRC | Investor Relations Contact | - | - |
Eddie L. Varnado
AUD | Comptroller/Controller/Auditor | - | 19-04-21 |
Aaron Schuchart
PRN | Corporate Officer/Principal | 59 | 06-05-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lota Zoth
BRD | Director/Board Member | 64 | 01-11-12 |
Richard Hawkins
CEO | Chief Executive Officer | 75 | 01-09-10 |
Kevin Lalande
BRD | Director/Board Member | 51 | 01-01-14 |
Thomas Raffin
BRD | Director/Board Member | 77 | 01-01-99 |
Joseph McCracken
BRD | Director/Board Member | 70 | 23-03-20 |
Director/Board Member | 64 | 13-02-21 | |
Director/Board Member | 45 | 01-03-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 139 661 | 5 289 307 ( 64,98 %) | 23 173 ( 0,2847 %) | 64,98 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,11% | 22,69 mln. | |
+4,09% | 43,84 mld. | |
+46,85% | 41,25 mld. | |
+9,45% | 41,68 mld. | |
-10,92% | 27,04 mld. | |
+9,32% | 25,53 mld. | |
-24,87% | 18,18 mld. | |
+29,70% | 12,29 mld. | |
+1,28% | 12,29 mld. | |
+7,78% | 11,15 mld. |
- Beurs
- Aandelen
- Koers LUMO
- Onderneming Lumos Pharma, Inc.